Levothroid
Levothroid Price range: $ 42,00 through $ 144,00
Back to products
Lida daidaihua
Lida daidaihua Price range: $ 52,00 through $ 171,00

Lexapro

Price range: $ 40,00 through $ 265,00

Lexapro is a highly effective medication belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder in both adults and adolescents. This medication is also officially indicated for the management of generalized anxiety disorder to help alleviate persistent feelings of nervousness. By balancing serotonin levels in the brain, it works to improve mood, sleep patterns, and overall energy. Many individuals find that Lexapro helps them regain emotional stability and enhances their daily quality of life.

Active substance: Escitalopram
SKU: Lexapro Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Lexapro belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). It is an FDA-approved prescription medication prescribed for the treatment of major depressive disorder and generalized anxiety disorder in specific patient populations.

As an Rx medication regulated by federal law in the United States, Lexapro must be taken strictly under the supervision of a licensed healthcare provider. The active pharmaceutical ingredient is escitalopram, provided as escitalopram oxalate in oral tablet and liquid formulations.

Property Details
Drug name Lexapro
Active ingredient Escitalopram (as escitalopram oxalate)
Therapeutic class Selective Serotonin Reuptake Inhibitor (SSRI)
Dosage form Oral tablet (5 mg, 10 mg, 20 mg), oral solution (1 mg/mL)
Route of administration Oral
Primary purpose Major depressive disorder, generalized anxiety disorder

How the drug works

Lexapro operates via selective inhibition of the presynaptic serotonin transporter (SERT). By blocking the reuptake of serotonin (5-hydroxytryptamine, or 5-HT) into the presynaptic neuron, the medication increases central serotonergic activity in the synaptic cleft. Escitalopram is the pure S-enantiomer of racemic citalopram and exhibits high affinity for the primary serotonin binding site, along with an allosteric binding action that enhances its affinity at the primary site. It demonstrates minimal affinity for dopamine or norepinephrine transporters, as well as muscarinic, histaminergic, or alpha-adrenergic receptors, which contributes to its selective pharmacological profile relative to older antidepressant classes.

What it’s used for

Lexapro is FDA-approved for the acute and maintenance treatment of major depressive disorder (MDD) in adults and adolescents aged 12 to 17 years. Additionally, it is FDA-approved for the management of generalized anxiety disorder (GAD) in adult populations. Beyond these official indications, clinicians may prescribe Lexapro for off-label uses, including obsessive-compulsive disorder (OCD), panic disorder, social anxiety disorder, and post-traumatic stress disorder (PTSD). Off-label use refers to prescribing a medication for a condition that has not received formal approval from the U.S. Food and Drug Administration, though such use may be supported by clinical practice guidelines.

Dosing schedule

Dosing for Lexapro varies based on the patient’s age, medical condition, and individual clinical response. For major depressive disorder in adults, the standard initial dose is 10 mg administered once daily, which may be increased to 20 mg daily after a minimum of one week if clinically indicated. For pediatric patients aged 12 to 17 years with MDD, the recommended starting dose is 10 mg once daily. For generalized anxiety disorder in adults, the recommended initial dose is 10 mg once daily. Doses exceeding 20 mg daily are generally not recommended due to increased safety risks without demonstrated additional clinical efficacy. Dose adjustments are recommended for elderly patients or those with severe hepatic impairment, where 10 mg daily is the recommended maximum dose.

What happens in the body

Following oral administration, escitalopram is absorbed efficiently, achieving peak plasma concentrations within approximately 5 hours after administration. The absolute bioavailability of escitalopram is estimated at approximately 80%, and its rate and extent of absorption are not significantly affected by food intake. Escitalopram exhibits plasma protein binding of roughly 56%. Biotransformation occurs extensively in the liver, primarily mediated by cytochrome P450 enzymes CYP2C19 and CYP3A4, into desmethyl and didesmethyl metabolites, which possess minimal pharmacological activity. The elimination half-life of Lexapro is approximately 27 to 32 hours in healthy young adults, extending longer in elderly patients or individuals with renal or hepatic impairment. Excretion occurs primarily through hepatic biotransformation and renal elimination.

Compatibility with other medicines

Lexapro exhibits important pharmacological interactions that require close clinical monitoring. Concomitant use with monoamine oxidase inhibitors (MAOIs) is strictly contraindicated due to the severe risk of serotonin syndrome; a 14-day washout period is required when transitioning between these agents. Concurrent administration with other serotonergic drugs–including linezolid, intravenous methylene blue, triptans, tramadol, and St. John’s Wort–increases serotonin toxicity risk. Combining Lexapro with nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, or oral anticoagulants like warfarin raises the risk of upper gastrointestinal bleeding due to altered platelet aggregation. Inhibitors or inducers of CYP2C19 may alter escitalopram clearance, requiring dose evaluations.

Adverse reactions

Commonly reported adverse effects associated with Lexapro include nausea, insomnia, somnolence, increased sweating, fatigue, dry mouth, and dizziness. Gastrointestinal disturbances often diminish after the initial weeks of therapy. Sexual dysfunction is a recognized effect of SSRI therapy; in male patients, this may manifest as ejaculatory delay or erectile dysfunction, whereas female patients may experience decreased libido or anorgasmia. Dose-dependent QT prolongation may occur, particularly in patients with pre-existing cardiac conditions or those taking concomitant QT-prolonging medications. Discontinuation symptoms such as dizziness, sensory disturbances (e.g., paresthesias), anxiety, and headache may manifest if treatment is abruptly terminated.

Important precautions

Lexapro carries an FDA Boxed Warning regarding an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults under 25 years old during initial therapy. Close clinical monitoring for worsening mood or unusual behavioral changes is essential. Lexapro is classified as a prescription medication and should be used cautiously in elderly patients due to an elevated risk of hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone secretion (SIADH). In pediatric populations, safety and effectiveness are established only for adolescents aged 12 and older with MDD. Pregnant or nursing women should consult their prescriber, as late third-trimester exposure may lead to neonatal complications or withdrawal symptoms in newborns.

First days of treatment

When starting Lexapro, patients often do not experience immediate therapeutic benefits. Mild side effects, such as initial nausea, drowsiness, or changes in sleep patterns, may emerge within the first few days of initiation. These early side effects frequently resolve as the body adapts to the medication over 1 to 2 weeks. Clinicians advise against stopping the medication prematurely due to initial mild discomfort, as full therapeutic benefits typically require several weeks of consistent use.

Signs of improvement

Evaluation of Lexapro’s clinical efficacy requires ongoing observation over weeks rather than days. Initial signs of improvement may include subtle enhancements in sleep architecture, energy levels, or appetite during the first 2 to 4 weeks. Meaningful reductions in depressed mood or pathological anxiety generally manifest between 4 and 8 weeks of consistent daily dosing. Healthcare providers evaluate progress through standardized clinical scales and patient-reported symptoms to determine whether dose adjustments are warranted.

What to avoid while taking it

Patients taking Lexapro should exercise caution regarding specific food, beverage, and substance interactions. Although food does not hinder absorption, consumption of alcohol should be avoided or strictly minimized, as alcohol can exacerbate central nervous system depression and impair motor skills. Additionally, over-the-counter dietary supplements containing St. John’s Wort or high-dose tryptophan should be avoided without medical approval due to the additive risk of excessive serotonergic activity.

If you skip a dose

If a dose of Lexapro is missed, it should be taken as soon as remembered, provided the next scheduled dose is not imminent. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Double doses must never be taken to compensate for a skipped dose. Maintaining a consistent daily administration routine helps maintain steady plasma concentration levels and reduces the risk of withdrawal-like symptoms.

Common questions

How long does it take for Lexapro to reach full clinical effect?

While some patients may notice subtle improvements in sleep or energy levels within 1 to 2 weeks, full therapeutic effects for depression or anxiety generally take 4 to 8 weeks of daily use. Consistent administration as prescribed is necessary to evaluate therapeutic response.

What happens if Lexapro is stopped suddenly?

Abrupt cessation of Lexapro can lead to discontinuation syndrome, characterized by symptoms such as dizziness, electric shock-like sensations, headache, anxiety, nausea, and irritability. Discontinuation should always involve a gradual tapering schedule supervised by a healthcare provider.

Does Lexapro alter cognitive performance or driving ability?

Lexapro may cause somnolence, fatigue, or dizziness in some individuals, particularly during initial titration. Patients should evaluate how the medication affects their alertness before operating machinery or driving a motor vehicle.

Is weight gain a potential side effect during long-term treatment with Lexapro?

Weight changes can occur during SSRI therapy. Some patients experience minor weight alterations due to changes in appetite or metabolic response over extended periods, though individual response varies significantly. Monitoring weight and discussing changes with a doctor is recommended.

How does Lexapro interact with common over-the-counter pain relievers?

Combining Lexapro with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or aspirin increases the risk of upper gastrointestinal bleeding. Patients requiring pain relief should consult a pharmacist or physician regarding safer alternatives, such as acetaminophen.

In accordance with FDA guidelines and official product labeling.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

5mg

,

10mg

,

20mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία